Abstract: Disclosed are monocyclic compounds containing four bifunctional residues linked together via peptide or pseudopeptide bonds of the general formula (I):
having tachykinin receptor antagonist activity. In particular, compounds of formula I are shown to be neurokinin-2 (NK-2) antagonists useful in the treatment or prevention of disorders of the central nervous system, inflammatory diseases, asthma, or pain.
Type:
Grant
Filed:
July 12, 2000
Date of Patent:
August 24, 2004
Assignee:
Menarini Ricerche S.p.A.
Inventors:
Raffaello Giorgi, Cristina Di Bugno, Danilo Giannotti, Carlo Alberto Maggi